Chairman of LyonHeart announces retirement

Share this article:
Al Nickel
Al Nickel

LyonHeart has announced the retirement of Al Nickel, the company's chairman. Anne Devereux, currently CEO, will replace Nickel in that position.

According to Devereux, Nickel was a founding partner in Dorritie Lyons & Nickel, Inc., which would later merge and evolve into Lyons Lavey Nickel Swift, Inc. (LLNS). In 2005, LLNS teamed with TBWA creating LyonHeart's global network TBWA\Worldwide, where Nickel was chairman. LLNS relaunched as LionHeart in 2007.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...